Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro

This publication has 50 references indexed in Scilit:

• Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus Retinitis
  New England Journal of Medicine, 1992
• Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus
  European Journal of Clinical Microbiology & Infectious Diseases, 1991
• Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique
  Antiviral Research, 1991
• Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro
  European Journal of Clinical Microbiology & Infectious Diseases, 1990
• A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts
  New England Journal of Medicine, 1989
• Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised Patients
  New England Journal of Medicine, 1989
• Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells
  Biochemical and Biophysical Research Communications, 1988
• Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)
  The Journal of Infectious Diseases, 1988
• Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation
  New England Journal of Medicine, 1988
• Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS
  Journal of Medical Virology, 1987